Identifying Rare Dermatologic Disorders in the Critical Care Setting - Episode 10
Spesolimab for Treatment of GPP
Published on:
Experts discuss spesolimab, an IL-36 inhibitor, that was recently FDA approved for treatment of GPP.
Identifying Rare Dermatologic Disorders in the Critical Care Setting - Episode 10
Experts discuss spesolimab, an IL-36 inhibitor, that was recently FDA approved for treatment of GPP.
